Spanish Association of Primary Care Pediatrics (AEPap)
If you are the contact person for this centre and you wish to make any changes, please contact us.
Pediatrician and collaborator of the Advisory Committee on Vaccines, the Spanish Association of Pediatrics and the Spanish Association of Primary Care Pediatrics
The NEJM publishes the results of a phase III clinical trial conducted by GSK that had to be suspended due to a safety signal. The study shows that newborns of vaccinated mothers had a lower risk of experiencing severe events associated with the respiratory syncytial virus (RSV), but also a higher risk of being born prematurely.
Toledo and Alicante are suffering the first outbreaks of measles recorded in Spain since the pandemic, El País reported today. In total, 15 cases have been confirmed since 1 January, of which seven are imported and eight autochthonous.
The European Medicines Agency (EMA) has recommended marketing authorisation in the European Union for Abrysvo vaccine to protect against respiratory syncytial virus (RSV) disease in infants up to six months of age. It is the first vaccine of its kind indicated for passive immunisation of newborns through administration to the mother during pregnancy. It is also indicated for people over 60 years of age. The European Commission now has to decide on its EU-wide marketing authorisation.
Researchers have analysed the efficacy of the meningococcal serogroup B vaccine (4CMenB, Bexsero) in more than 1,500 children under five years of age in Spain. The research, published in the New England Journal of Medicine, shows that full vaccination was effective in preventing invasive meningococcal disease of both serogroup B and other serogroups in this child population. The vaccine, which had been sold privately in Spain since 2015, had already been included by several autonomous communities in their vaccination schedules. Last December, the Interterritorial Council of the National Health System (CISNS) approved its inclusion in the vaccination schedule for the whole of Spain.
According to estimates by the United Nations Inter-Agency Group for Child Mortality Estimation (UN-IGME) published by UNICEF, in 2021 some 5 million children died before their fifth birthday, and another 2.1 million children and young people did it between the ages of 5 and 24. Additionally, 1.9 million babies were stillborn during the same period.
The European Medicines Agency (EMA) has recommended marketing authorisation in the European Union for Beyfortus (nirsevimab) to prevent respiratory syncytial virus (RSV) lower respiratory tract disease in babies and infants. The agency recommends it during its first RSV season. The European Commission now has to decide on its marketing authorisation across the EU.
Según datos de la OMS y UNICEF, 25 millones de niños no han recibido sus vacunas contra la difteria, el tétanos y la tosferina (DTP) a nivel global. Se trata de la mayor caída continuada en cobertura vacunal en casi treinta años.
Respiratory Syncytial Virus (RSV) was responsible for more than 100,000 deaths in children under the age of five worldwide in 2019, a study published in The Lancet estimates. The authors highlight the "urgent need" for vaccines.
On 27 April, the WHO reported 151 cases of salmonellosis in 11 countries, caused by the consumption of 'kinder eggs' or other contaminated products of the same brand. In Spain, two cases have been confirmed.
The recommendation is to vaccinate children from 5 to 11 years old with the vaccine approved in Europe for this age group, Comirnaty (Pfizer) with one third of the dose used in children over 12 years old. But parents still have doubts. Here we answer the classic ones (safety, risk/benefit) and other more specific ones: allergies, genetic syndromes, high-risk individuals...